LLY vs PYPL: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and PayPal Holdings, Inc. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Eli Lilly and Company ยท Healthcare
$1,098.13
+16.7% upside to fair value
Grade B
High Quality
VS
PayPal Holdings, Inc. ยท Financial Services
$42.51
+45.0% upside to fair value
Grade B
QuantHub Verdict
PYPL has more upside to fair value
(+45.0%).
PYPL trades at a lower forward P/E
(7.7x).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
LLY |
PYPL |
| Current Price |
$1,098.13 |
$42.51 |
| Fair Value Estimate |
$1,281.02 |
$61.64 |
| Upside to Fair Value |
+16.7%
|
+45.0%
|
| Market Cap |
$1,034.2B |
$37.5B |
| Forward P/E |
38.9x
|
7.7x
|
| EV / EBITDA |
32.0x
|
5.3x
|
| Price / Sales |
14.3x
|
1.1x
|
| Price / FCF |
76.2x
|
6.8x
|
| Revenue Growth YoY |
+55.5%
|
+7.2%
|
| Gross Margin |
83.5%
|
46.1%
|
| Operating Margin |
45.9%
|
17.9%
|
| Return on Equity |
101.3%
|
25.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.31%
|
14.71%
|
| Analyst Consensus |
Strong Buy
|
Sell
|
Investment Thesis
Eli Lilly and Company is a leading healthcare firm specializing in drug manufacturing with a strong competitive moat in GLP-1 diabetes and obesity treatments as well as biologics manufacturing. The company is led by experienced internal management with a proven capital allocation track record. Its revenue growth is exceptionally strong, driven by its cardiometabolic franchise which accounted for โฆ
PayPal Holdings, Inc. operates as a leading global digital payments platform with a competitive moat driven by its extensive network effects, brand recognition, and scale. Despite a durable business model with 2025 revenue of $33.17 billion growing at 4.3% year-over-year and a strong return on equity of 25.1%, the company faces slowing growth and margin pressures, reflected in a 13.5% decline in โฆ
Accumulation Zones
| Metric |
LLY |
PYPL |
| Zone Low |
$960.76 |
$46.23 |
| Zone High |
$1,088.87 |
$52.39 |
| In Buy Zone? |
No
|
Yes
|